SPHK1 and colitis: Inhibition of sphingosine kinase 1 (SK1), either by inhibitors or using SK1-ko mice, ameliorates DSS-induced colitis in mice [35,42], whereas downregulation of SK2 enhanced DSS-induced colitis in mice, which has been ascribed to a concomitant upregulation of SK1 in these mice [43].